北京市中伦律师事务所 关于沈阳富创精密设备股份有限公司 属期归属条件成就、2023 年限制性股票激励计划与 分限制性股票相关事宜 的法律意见书 北京 • 上海 • 深圳 • 广州 • 武汉 • 成都 • 重庆 • 青岛 • 杭州 • 南京 • 海口 • 东京 • 香港 • 伦敦 • 纽约 • 洛杉矶 • 旧金 山 • 阿拉木图 Beijing • Shanghai • Shenzhen • Guangzhou • Wuhan • Chengdu • Chongqing • Qingdao • Hangzhou • Nanjing • Haikou • Tokyo • Hong Kong • London • New York • Los Angeles • San Francisco • Almaty 北京市中伦律师事务所 关于沈阳富创精密设备股份有限公司 件成就、2023 年限制性股票激励计划与 2024 年限制性股票激 励计划调整授予价格及作废部分限制性股票相关事宜 的法律意见书 致：沈阳富创精密设备股份有限公司 根据沈阳富创精密设备股份有限公司（以下简称"富创精密"、"公司"） 与北京市中伦律师事务所（ ...

Core Viewpoint - The company has announced the cancellation of a portion of the 2023 restricted stock incentive plan due to certain recipients no longer qualifying for the incentive [1][6]. Group 1: Approval Process and Disclosure - The company held board and supervisory meetings to approve the draft of the 2023 restricted stock incentive plan and its management measures [1][2]. - Independent directors provided their opinions on the related proposals, ensuring compliance with regulations [1][2]. Group 2: Cancellation Details - A total of 43.4736 thousand shares of restricted stock will be canceled due to 26 individuals no longer qualifying and 13 individuals not meeting performance criteria [5][6]. - The cancellation includes 36.5982 thousand shares from the initial grant and 5.7035 thousand shares from the reserved grant [5][6]. Group 3: Impact on the Company - The cancellation of the restricted stock will not have a substantial impact on the company's financial status or operational results [6]. - The board and supervisory committee agree that the cancellation aligns with relevant laws and regulations, ensuring no harm to the company's or shareholders' interests [6][7]. Group 4: Legal Opinions - The legal opinion confirms that the adjustments and cancellations have received necessary approvals and comply with applicable laws and regulations [7].

Group 1 - The core viewpoint of the article is the approval of the 2024 Restricted Stock Incentive Plan by the Compensation and Assessment Committee of the company, confirming the eligibility of the reserved grant recipients [1] - The reserved grant recipients do not fall under any disqualifications as per the relevant regulations, including being recognized as inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months [1] - The list of reserved grant recipients excludes independent directors, shareholders holding more than 5% of shares, and the actual controller of the company along with their immediate family members [1] - The reserved grant recipients meet the qualifications stipulated in the company's articles of association and relevant laws, confirming their eligibility for the 2024 Restricted Stock Incentive Plan [1]

Meeting Overview - The second session of the second Supervisory Board of Shenyang Fuchuang Precision Equipment Co., Ltd. was held on July 7, 2025, with all three supervisors present, ensuring the legality and validity of the meeting [1][2]. Resolutions Passed - The Supervisory Board approved the adjustment of the grant price for the 2023 and 2024 restricted stock incentive plans, confirming compliance with relevant laws and regulations, and ensuring no harm to the interests of the company and its shareholders [2][3]. - The resolution to void part of the restricted stocks from the 2023 and 2024 incentive plans was also approved, adhering to legal requirements and not harming shareholder interests [3][4]. - The board confirmed that 218 incentive targets met the conditions for the second vesting period of the 2023 restricted stock incentive plan, with 80% of the company-level and individual performance criteria being met [4].

Core Points - The Supervisory Board of Shenyang Fuchuang Precision Equipment Co., Ltd. has verified the list of incentive objects eligible for the second vesting period of the 2023 restricted stock incentive plan [1] - A total of 218 incentive objects meet the conditions set forth in relevant laws and regulations, with 80% of the company-level and individual performance assessment indicators qualifying for vesting [1] - The Supervisory Board has approved the vesting of 356,221 restricted shares for the eligible 218 incentive objects [2]

Core Points - The Supervisory Board of Huahai Qingke Co., Ltd. has reviewed the first vesting list of the 2023 restricted stock incentive plan and confirmed that 231 incentive objects meet the eligibility criteria as per relevant laws and regulations [1][2] - A total of 939,134 shares of restricted stock will be granted to the eligible 231 incentive objects, which aligns with the provisions of the management measures and the company's incentive plan draft [2] Summary by Sections - **Eligibility of Incentive Objects** - Out of the initial group, 26 individuals were disqualified due to resignation or voluntary withdrawal, leaving 231 eligible incentive objects [1] - The eligibility of these 231 individuals complies with the Company Law and Securities Law, confirming their legal and valid status as incentive objects [1] - **Stock Grant Details** - The total number of restricted stocks to be granted to the eligible incentive objects is 939,134 shares [2] - The decision to grant these shares does not harm the interests of the company or its shareholders, adhering to the relevant regulations [2]

Group 1 - The company held its fourth supervisory board meeting on July 7, 2025, with all three supervisors present, confirming the legality and validity of the meeting procedures [1] - The supervisory board approved the proposal regarding the lifting of the first lock-up period for the 2024 restricted stock incentive plan, as the performance indicators for the release conditions have been met, allowing for the release of 0.25% of the total share capital for eligible incentive objects [2][3] - The supervisory board also agreed to the repurchase and cancellation of restricted stocks that were granted to departing incentive objects but have not yet been released, confirming compliance with relevant laws and regulations [2][3]

杭州解百集团股份有限公司监事会 二〇二五年七月七日 杭州解百集团股份有限公司 第十一届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 鉴于 1 名激励对象因主动辞职与公司终止劳动关系，根据《激励计划》相关规 定，公司监事会同意回购注销前述 1 名激励对象已获授但尚未解除限售的限制性股 票合计 27,000 股。另外，因公司 2023 年度和 2024 年度权益分派方案已实施完毕， 根据《上市公司股权激励管理办法》《杭州解百集团股份有限公司 2021 年限制性股 票激励计划》等相关规定，公司监事会同意将回购价格调整至 2.559 元/股。 表决结果：同意 5 票，反对 0 票，弃权 0 票，表决通过。 特此公告。 杭州解百集团股份有限公司（以下简称"公司"）于 2025 年 7 月 7 日以现场会 议方式在杭州市环城北路 208 号坤和中心 37 楼会议室召开了第十一届监事会第十三 次会议。本次会议通知于 2025 年 6 月 19 日以通讯方式送达各位监事，会议应参加 监事 5 人，实际参加监 ...

Core Viewpoint - The announcement details the completion of the initial registration for the 2025 Restricted Stock Incentive Plan by Shanghai NAR Industrial Co., Ltd, highlighting the approval processes, stock allocation, and performance assessment criteria for the incentive plan [1][2][3]. Summary by Sections Approval Process - The 2025 Restricted Stock Incentive Plan has undergone necessary approval procedures, including the review and consent from the Compensation and Assessment Committee of the Board [1][2]. - No objections were raised during the public notice period by the Supervisory Board [1]. Initial Grant of Restricted Stock - A total of 91.706 million shares were granted to 37 core personnel, representing 19.74% of the incentive plan and 0.27% of the total share capital on the announcement date [2][3]. - The effective period of the incentive plan is up to 48 months from the date of the initial grant [2]. Lock-up Period and Release Schedule - The lock-up periods for the granted restricted stocks are set at 12, 24, and 36 months, with specific release percentages of 35% for the first two periods and 30% for the last [3][4]. Performance Assessment Criteria - The performance assessment for the incentive plan will be based on the company's total revenue and net profit for the fiscal years 2025-2027, with specific targets set for each assessment year [5][6]. - The performance targets are equally weighted, with a 50% contribution from both revenue and profit metrics [6]. Financial Impact and Fund Utilization - The funds raised from the stock grants will be used to supplement the company's working capital [8]. - The issuance of restricted stocks will have an impact on the company's financial status, with specific amortization costs outlined for the years 2025 to 2028 [8][9]. Stock Structure Changes - Following the completion of the grant registration, the total number of shares increased to 341,535,127, with no change in the control of the company or its compliance with listing conditions [7][8].

截至2025年7月4日收盘，天臣医疗（688013）报收于29.99元，较上周的27.31元上涨9.81%。本周，天 臣医疗7月4日盘中最高价报31.96元，股价触及近一年最高点。6月30日盘中最低价报27.47元。天臣医疗 当前最新总市值24.34亿元，在医疗器械板块市值排名115/126，在两市A股市值排名4712/5149。 公司于2025年7月3日完成2023年限制性股票激励计划第二个归属期的股份登记工作。本次归属股票数量 为556,000股，来源于公司从二级市场回购的A股普通股股票，归属人数为89人。公司实际收到89名激励 对象缴纳的资本总额共计人民币5,977,000.00元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 天臣国际医疗科技股份有限公司于2023年12月27日开始实施股份回购计划，回购资金总额逐步调整为不 低于4600万元，不超过8000万元，回购期限延长至2025年12月26日。截至2025年6月30日，公司已累计 回购股份2505324股，占公司总股本的3.09%，支付的资金总额约为4249.89万 ...